Nobel Pharma Inc.
Founded in 1964 and fully owned by local shareholders, Nobel İlac operates extensive R&D activities for the purposes of innovation and completely innovative drug development in generic dosage forms. The company also has production facilities for finished products, as well as a separate production facility (Ulkar Kimya) that manufacture raw material and micro pellets. Both facilities have GMP certificates approved by the EU.
Two production facilities of Nobel İlac in Kazakhstan and Uzbekistan are capable of manufacturing and licensing their own finished products. Nobel İlac has over 1000 drug licenses abroad, and more than 200 in Turkey.
Nobel, which has one of the largest field networks in Turkey with its 1000 medical representatives and 95 regional managers, operates its activities outside Turkey through its representation offices employing over 400 medical representatives and 782 employees in total throughout Asia and Europe.
Activities of Nobel are supported by Ulkar Kimya (raw material and micro pellet manufacturing), Nobelfarma (finished product manufacturing in every form), and Fargem (R&D), all members of the same group of companies.